Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Strategic Communication and Public Relations

Awakening of dormant hematopoietic stem cells

© dkfz.de

The often occurring relapse of cancers after initially successful chemo- and radiation therapy is thought to be due to the presence of some therapy resistant cancer stem cells within the original tumor. These malignant stem cells share many characteristics with normal stem cells, which show high resistance to such therapies, too. Marieke Essers and Andreas Trumpp from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and HI-STEM together with Anne Wilson from the Ludwig Institute of Cancer Research in Lausanne have just published an opinion paper in “Nature Reviews Immunology” proposing a novel model in which hematopoietic stem cells (HSCs) are localized in three different microenvironments called niches, which produce signals that are not only critical to maintain their stem cell self-renewal potential as well as their proliferative activity, but also provide environments that support stem cell function during repair processes initiated after tissue injury. The authors suggest that hematopoietic stem cells (HSCs) dynamically migrate between these three different niches, depending on whether they are dormant or self-renewing during steady-state homeostasis, or whether they are activated and rapidly dividing under conditions of stress. Moreover, they summarize data showing that the most potent HSCs are in a deeply dormant phase during homeostasis, which is accompanied by a striking resistance to chemotherapeutic drugs. Interestingly, three different factors (Granulocyte-Colony-Stimulating-Factor, Interferon-á, and Arsenic-Trioxide) have recently been shown to efficiently activate dormant hematopoietic stem cells and thereby break their resistance to anti-proliferative chemotherapeutics. These data suggest a two-step strategy in which dormant cancer cells need to be activated first before they can be eliminated by chemotherapies. This hypothesis can now be clinically tested for hematological malignancies.

Reference:
Trumpp A, Essers M, Wilson A.
Awakening dormant haematopoietic stem cells.
Nat Rev Immunol. 2010 Mar;10(3):201-9.
PMID: 20182459 doi:10.1038/nri2726

to top
powered by webEdition CMS